STEPHANIE PRICE: Open Payments
NPI 1487948774 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 29 payments from 6 companies in 2025. Trend: 2023 $805 · 2024 $750 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $276 |
| Supernus Pharmaceuticals, Inc. | 7 | $249 |
| Axsome Therapeutics, Inc. | 4 | $163 |
| Otsuka America Pharmaceutical, Inc. | 3 | $151 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
Products named: VRAYLAR, Qelbree, Auvelity, REXULTI, Jornay PM, INGREZZA.
Industry payments across SC — which companies pay providers there.
